BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer

Shunan Wang, Xinyu Liu, Meng Yang, Dongqi Yuan, Kui Ye, Xin Qu, Xinchao Wang

Disease Markers · 2022 · 16 citations · 17 references

DOIFull text

Open access

Abstract

We speculate that BUB1, BUB1B, and BUB3 may be therapeutic targets for BrCa patients and also provide new therapeutic strategies for BrCa treatment.

References

17